Hatou Shin

ハトウシン | Hatou Shin

Affiliation and department：

Research field (1)： Ophthalmology

Research keywords (4)： Transplant , Cornea , Regenerative medicine , Ophthalmology

Research theme for competitive and other funds (5)：

2021 - 2024 Semaphorin 3a による角膜上皮創傷治癒および炎症メカニズムの解明
2016 - 2019 Elucidating the pathogenesis of Fuchs corneal dystrophy using disease iPSCs
2015 - 2018 Immunological properties of corneal endothelial cells derived from human induced pluripotent stem cells
2008 - 2009 Activation and regulation of the pump function of corneal endothelium.
2002 - 2003 肺形態形成の正常および低形成肺モデルにおける遺伝子発現制御に関する研究

Papers (46)：

Shigeto Shimmura, Emi Inagaki, Masatoshi Hirayama, Shin Hatou. The Cornea: An Ideal Tissue for Regenerative Medicine. The Keio journal of medicine. 2024. 73. 1. 1-7
Saki Sakakura, Emi Inagaki, Tomoko Sayano, Risa Yamazaki, Noemi Fusaki, Shin Hatou, Masatoshi Hirayama, Kazuo Tsubota, Kazuno Negishi, Hideyuki Okano, et al. Non-apoptotic regulated cell death in Fuchs endothelial corneal dystrophy. Regenerative therapy. 2023. 24. 592-601
Shin Hatou, Shigeto Shimmura. Advances in corneal regenerative medicine with iPS cells. Japanese journal of ophthalmology. 2023. 67. 5. 541-545
清水翔太, 谷口ヒロ子, 佐藤真理, 羽藤晋, 平山雅敏, 榛村重人, 根岸一乃. 涙腺神経切断モデルマウスにおけるSemaphorin3a阻害剤のドライアイ治療効果の評価. 日本眼科学会雑誌. 2023. 127. 臨増. 290-290
清水翔太, 谷口ヒロ子, 佐藤真理, 羽藤晋, 平山雅敏, 榛村重人, 根岸一乃. 涙腺神経切断モデルマウスにおけるSemaphorin3a阻害剤のドライアイ治療効果の評価. 日本眼科学会雑誌. 2023. 127. 臨増. 290-290

ｍore...

MISC (97)：

ｍore...

Education (2)：

2009 - 2013 Graduate School of Medicine, Keio University MD-PhD program Ophthalmology
1992 - 1998 Keio University School of Medicine

Awards (2)：

2015/03 - Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical’s Founder
2013/02 - Japan Cornea Society award

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page